Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 14.3M | 12.9M | 12.0M | 9.3M |
| Selling general and admin | 7.8M | 8.2M | 7.0M | 5.5M |
| Other operating expenses | -342K | -234K | -369K | -526K |
| Operating income | -21.8M | -20.9M | -18.6M | -14.3M |
| Non operating interest income | ||||
| Income | 2.4M | 2.6M | 3.6M | 3.1M |
| Expense | 128K | -73K | 69K | 23K |
| Other income expense | 1.4M | -24.1M | — | -4K |
| Pretax income | -18.2M | -42.3M | -15.1M | -11.2M |
| Tax provision | — | -2.1M | 0 | 0 |
| Net income | -18.2M | -40.2M | -15.1M | -11.7M |
| Basic EPS | -0.3 | — | -0.2 | -0.2 |
| Diluted EPS | -0.3 | — | -0.2 | -0.2 |
| Basic average shares | 81.0M | — | 79.1M | 74.6M |
| Diluted average shares | 81.0M | — | 79.1M | 74.6M |
| EBITDA | -17.3M | -17.5M | -14.4M | -10.6M |
| Net income from continuing op. | -18.2M | -40.2M | -15.1M | -11.7M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |